Noninvasive Markers Aid Risk Assessment of Prostate Cancer
THURSDAY, May 13, 2021 -- Integration of data from multiple, noninvasive biomarkers can improve risk assessment of patients with a clinical suspicion of prostate cancer prior to an invasive biopsy, according to a study published online April 27 in Cancers.
Shea P. Connell, from Norwich Medical School at the University of East Anglia in the United Kingdom, and colleagues developed a multivariable risk model (ExoGrail) for the noninvasive detection of prostate cancer prior to biopsy that integrates information from clinically available parameters, Engrailed-2 (EN2) whole-urine protein levels, and data from urinary cell-free RNA; 207 patients were included in the analyses.
The researchers reported that ExoGrail risk (range, 0 to 1) was able to determine the outcome of an initial transrectal ultrasound biopsy more accurately than clinical standards of care, predicting the presence of any cancer with an area under the curve (AUC) of 0.89 and discriminating more aggressive disease (Gleason ≥3 + 4) with an AUC of 0.84. For each 0.1 ExoGrail increase, the likelihood of more aggressive disease being detected significantly increased (odds ratio, 2.21). Compared with the current standard of care, decision curve analysis of the net benefit of ExoGrail showed the potential to reduce the numbers of unnecessary biopsies by 35 percent.
"Discriminating disease status in patients before a diagnostic biopsy with higher accuracy than current standards could bring about a sizeable change in treatment pathways and reduce the number of men sent forward for ultimately unnecessary biopsy," the authors write.
A patent application has been filed by the authors for the present work and work related to this.
© 2021 HealthDay. All rights reserved.
Posted May 2021
Read this next
THURSDAY, June 17, 2021 -- A coronavirus state of emergency in Tokyo and six other areas will be downgraded when it expires on Sunday as new daily cases continue to decline, the...
THURSDAY, June 17, 2021 -- There are persistent racial/ethnic disparities in drowning death rates in the United States, according to research published in the June 18 issue of the...
THURSDAY, June 17, 2021 -- The landmark Affordable Care Act, which has expanded health care coverage to tens of millions of Americans, has withstood a third challenge before the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.